Executive summary In September, 2015, the member states of the UN endorsed Sustainable
Development Goals (SDGs) for 2030, which aspire to human-rights-centred approaches to …

The opioid epidemic has fueled infectious disease epidemics. We determined the impact of
medications for opioid use disorder (MOUD) on treatment outcomes of opioid use disorder …

Medication treatment for opioid use disorder with methadone and buprenorphine is a key
HIV prevention strategy [1–5]. Enrollment in medication treatment for opioid use disorder is …

Background Methadone maintenance therapy (MMT) continues to be a key treatment for
opioid use disorder, although premature discontinuation of MMT can increase risk for …

Highlights•Intersectional stigma research examining pathways to HIV outcomes is
limited.•Adapted conceptual frameworks to examine intersectional stigma and health …

Despite high rates of cannabis use during medication-based treatment of opioid use
disorder (MOUD), uncertainty remains around how cannabis influences treatment outcomes …

Extra-medical prescription opioid (EMPO) use–intentional use without a prescription or
outside of prescribed parameters–is a public health crisis in the United States and around …

Human immunodeficiency virus type 1 is associated with the development of neurocognitive
disorders in many infected individuals, including a broad spectrum of motor impairments and …

Abstract Purpose of Review People who use drugs face multiple challenges to achieve
optimal HIV treatment outcomes. This review discusses the current knowledge in substance …

We used latent class analysis to identify substance use patterns for 1363 women living with
HIV in Canada and assessed associations with socio-economic marginalization, violence …